About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions

Citation:

Interventional Cardiology Review 2019;14(2):89–94.

‘Primary’ Microvascular Angina: Clinical Characteristics, Pathogenesis and Management

Citation:

Interventional Cardiology Review 2018;13(3):108–11

Culprit Vessel Only Versus Complete Revascularisation in Patients with ST-Segment Elevation Myocardial Infarction – Should we Stay or Stage?

Citation:

Interventional Cardiology Review 2018;13(3):129–34.

ORBITA: What Goes Around, Comes Around… Or Does It?

Citation:

Interventional Cardiology Review 2018;13(3):135–6.